• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Extended use of sulodexide, apixaban, rivaroxaban and dabigatran in venous thromboembolism: indirect comparison of clinical trials.

作者信息

Tomkowski Witold, Kuca Paweł, Bignamini Angelo A, Andreozzi Giseppe M

机构信息

Polish Foundation against Thrombosis, National Tuberculosis and Lung Diseases Research Institute, Cardio-Pulmonary Intensive Care, Warsaw, Poland.

Polish Foundation against Thrombosis, National Tuberculosis and Lung Diseases Research Institute, Cardio-Pulmonary Intensive Care, Warsaw, Poland -

出版信息

Int Angiol. 2017 Oct;36(5):496-497. doi: 10.23736/S0392-9590.17.03819-6. Epub 2017 Jun 21.

DOI:10.23736/S0392-9590.17.03819-6
PMID:28641408
Abstract
摘要

相似文献

1
Extended use of sulodexide, apixaban, rivaroxaban and dabigatran in venous thromboembolism: indirect comparison of clinical trials.
Int Angiol. 2017 Oct;36(5):496-497. doi: 10.23736/S0392-9590.17.03819-6. Epub 2017 Jun 21.
2
Evaluation of oral anticoagulants for the extended treatment of venous thromboembolism using a mixed-treatment comparison, meta-analytic approach.采用混合治疗比较的荟萃分析方法评估口服抗凝剂用于静脉血栓栓塞症的长期治疗。
Clin Ther. 2014 Oct 1;36(10):1454-64.e3. doi: 10.1016/j.clinthera.2014.06.033. Epub 2014 Aug 3.
3
Modern Treatment Modalities and Duration of Treatment for Venous Thromboembolism.静脉血栓栓塞症的现代治疗方式及治疗时长
Ther Umsch. 2016;73(10):618-625. doi: 10.1024/0040-5930/a000833.
4
[Not Available].[无可用内容]
Lakartidningen. 2018 Dec 4;115:FAS3.
5
Dabigatran, rivaroxaban and apixaban for extended venous thromboembolism treatment: network meta-analysis.达比加群、利伐沙班和阿哌沙班用于延长静脉血栓栓塞症治疗：网状Meta分析。
Int Angiol. 2014 Aug;33(4):301-8.
6
Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis.非维生素K拮抗剂口服抗凝剂阿哌沙班、达比加群和利伐沙班在静脉血栓栓塞症长期治疗和预防中的比较：系统评价与网状Meta分析
PLoS One. 2016 Aug 3;11(8):e0160064. doi: 10.1371/journal.pone.0160064. eCollection 2016.
7
Safety ad efficacy of direct oral anticoagulants for extended treatment of venous thromboembolism.直接口服抗凝剂用于静脉血栓栓塞症长期治疗的安全性和有效性。
Intern Emerg Med. 2016 Oct;11(7):895-900. doi: 10.1007/s11739-016-1521-8. Epub 2016 Aug 22.
8
Antidotes to non-vitamin K oral anticoagulants: necessary or not?非维生素K口服抗凝剂的解毒剂：是否必要？
Expert Opin Pharmacother. 2015;16(11):1573-6. doi: 10.1517/14656566.2015.1057119. Epub 2015 Jun 16.
9
Drug Treatment of Venous Thromboembolism in the Elderly.老年人静脉血栓栓塞症的药物治疗
Drugs Aging. 2016 Jul;33(7):475-90. doi: 10.1007/s40266-016-0378-x.
10
Pharmacologic Reversal of Direct Oral Anticoagulants.直接口服抗凝剂的药理学逆转
Crit Care Nurs Q. 2018 Apr/Jun;41(2):121-128. doi: 10.1097/CNQ.0000000000000193.